Home
Market Capitalization of Gland Pharma Ltd

Gland Pharma Ltd
NSE: GLAND
Market Cap
Key Highlights
- The Market Cap of Gland Pharma Ltd is ₹ 23499 crore as of 09 May 25 .
- The Latest Trading Price of Gland Pharma Ltd is ₹ 1426 as of 09 May 15:30 .
- The Dividend Payouts of Gland Pharma Ltd is ₹ 20 as of Aug 16, 2024 .

Gland Pharma Ltd
NSE: GLAND
Share Price
Market Price of Gland Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
09 May 2025 | 1426.3 |
08 May 2025 | 1413.5 |
07 May 2025 | 1403.45 |
06 May 2025 | 1414.2 |
05 May 2025 | 1418.75 |
02 May 2025 | 1404.7 |
30 Apr 2025 | 1398.35 |
29 Apr 2025 | 1413 |
28 Apr 2025 | 1412.95 |
25 Apr 2025 | 1451.35 |
SWOT Analysis Of Gland Pharma Ltd
BlinkX Score for Gland Pharma Ltd
Asset Value vs Market Value of Gland Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Gland Pharma Ltd
Historical P/E Ratio of Gland Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Gland Pharma Ltd
Historical Revenue of Gland Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Gland Pharma Ltd
Historical EBITDA of Gland Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Gland Pharma Ltd
Historical Net Profit of Gland Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Gland Pharma Ltd

Gland Pharma Ltd
NSE: GLAND
DIVIDENDPAYOUT
About Gland Pharma Ltd
- Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
- Subsequently, the name of the Company was changed to Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
- The Company is primarily engaged in manufacturing injectable formulations. The company is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019.
- The company has 8 manufacturing facilities in India, comprising four finished formulations facilities with a total of 23 production lines and three API facilities.
Gland Pharma Ltd News Hub
Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr
Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s
Read more
07 Aug 24
Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter
Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai
Read more
06 Aug 24
US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility
The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c
Read more
05 Aug 24
Gland Pharma Ltd gains for third straight session
Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1
Read more
09 Sept 24